Sc Pharmaceuticals scheduled to receive FDA approval for expanded use of FUROSCIX on August 08 2024

- Company: Sc Pharmaceuticals - FDA has set pdufa deadline on Saturday, August 10, 2024 - Approval news likely to be released on Thursday, August 08, 2024 afterhours - Stock expected to increase 10-15% after news release, then go negative the following trading day - Similar to Akebia Therapeutics - Recommendation: Buy stock before news, sell after news release, buy $5 strike put options expiring 08/16/2024 at market open following day